TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database

Abstract

Target identification of the known bioactive compounds and novel synthetic analogs is a very important research field in medicinal chemistry, biochemistry, and pharmacology. It is also a challenging and costly step towards chemical biology and phenotypic screening. In silico identification of potential biological targets for chemical compounds offers an alternative avenue for the exploration of ligand-target interactions and biochemical mechanisms, as well as for investigation of drug repurposing. Computational target fishing mines biologically annotated chemical databases and then maps compound structures into chemogenomical space in order to predict the biological targets. We summarize the recent advances and applications in computational target fishing, such as chemical similarity searching, data mining/machine learning, panel docking, and the bioactivity spectral analysis for target identification. We then described in detail a new web-based target prediction tool, TargetHunter (http://www.cbligand.org/TargetHunter). This web portal implements a novel in silico target prediction algorithm, the Targets Associated with its MOst SImilar Counterparts, by exploring the largest chemogenomical databases, ChEMBL. Prediction accuracy reached 91.1% from the top 3 guesses on a subset of high-potency compounds from the ChEMBL database, which outperformed a published algorithm, multiple-category models. TargetHunter also features an embedded geography tool, BioassayGeoMap, developed to allow the user easily to search for potential collaborators that can experimentally validate the predicted biological target(s) or off target(s). TargetHunter therefore provides a promising alternative to bridge the knowledge gap between biology and chemistry, and significantly boost the productivity of chemogenomics researchers for in silico drug design and discovery.

Phytotherapy: Herbal medicine in the management of Diabetes mellitus

“…Molecular docking of a compound is one of the widely used methods to determine the potential partner of the proteins in silico (8). Past research (9,10,11) analyzed the phytochemicals reported in these four plants for their binding affinity towards the enzymes those plays an important role in the management of diabetes.…”

Advances in recent patent and clinical trial drug development for Alzheimer’s disease

“…Of course, it is a challenge to apply such multidrug remedies for AD treatment with clinical rationale. Thus, new approaches such as quantitative system pharmacology with computational system polypharmacology algorithms [157,158] and chemogenomics knowledgebases [159,160] will open up a broad and promising avenue to advance the discovery and development of new-generation drugs for AD in the future.…”

Scaling machine learning for target prediction in drug discovery using Apache Spark

“…An alternative is virtual screening: the identification of candidate compounds through computation [2,3,4,5]. Inside Janssen Pharmaceutica, a method is used which takes advantage of the fact that compounds with a similar structure often interact similarly with the same proteins.…”